Time to achieve clearing with topical carmustine.
Zackheim
H S
HS
D000279:Administration, Cutaneous; D002330:Carmustine / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D016410:Lymphoma, T-Cell, Cutaneous / Q000188:drug therapy*; D012074:Remission Induction; D012878:Skin Neoplasms / Q000188:drug therapy*; D013997:Time Factors
D002330:Carmustine